The toxic effect of silver ions and silver nanoparticles towards bacteria and human cells occurs in the same concentration range

Silver is commonly used both in ionic form and in nanoparticulate form as a bactericidal agent. This is generally ascribed to a higher toxicity towards prokaryotic cells than towards mammalian cells. Comparative studies with both silver ions (such as silver acetate) and polyvinylpyrrolidone (PVP)-stabilized silver nanoparticles (70 nm) showed that the toxic effect of silver occurs in a similar concentration range for Escherichia coli, Staphylococcus aureus, human mesenchymal stem cells (hMSCs), and peripheral blood mononuclear cells (PBMCs), i.e. 0.5 to 5 ppm for silver ions and 12.5 to 50 ppm for silver nanoparticles. For a better comparison, bacteria were cultivated both in Lysogeny broth medium (LB) and in Roswell Park Memorial Institute medium (RPMI)/10% fetal calf serum (FCS) medium, as the state of silver ions and silver nanoparticles may be different due to the presence of salts, and biomolecules like proteins. The effective toxic concentration of silver towards bacteria and human cells is almost the same.

[1]  Alexander M Seifalian,et al.  Nanosilver as a new generation of nanoproduct in biomedical applications. , 2010, Trends in biotechnology.

[2]  G. Sotiriou,et al.  Antibacterial activity of nanosilver ions and particles. , 2010, Environmental science & technology.

[3]  G. Eggeler,et al.  Cell type-specific responses of peripheral blood mononuclear cells to silver nanoparticles. , 2011, Acta biomaterialia.

[4]  S. Bhoraskar,et al.  Silver nanoparticle studded porous polyethylene scaffolds: bacteria struggle to grow on them while mammalian cells thrive. , 2011, Nanoscale.

[5]  H. Klasen,et al.  A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. , 2000, Burns : journal of the International Society for Burn Injuries.

[6]  María Vallet-Regí,et al.  The influence of proteins on the dispersability and cell-biological activity of silver nanoparticles , 2010 .

[7]  K. Paknikar,et al.  Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. , 2009, Molecular pharmaceutics.

[8]  J. Alexander,et al.  History of the medical use of silver. , 2009, Surgical infections.

[9]  D. Brett.  A discussion of silver as an antimicrobial agent: alleviating the confusion. , 2006, Ostomy/wound management.

[10]  Iseult Lynch,et al.  Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. , 2011, Journal of the American Chemical Society.

[11]  P. Tam,et al.  Silver nanoparticles: partial oxidation and antibacterial activities , 2007, JBIC Journal of Biological Inorganic Chemistry.

[12]  Lydie Ploux,et al.  Tunable antibacterial coatings that support mammalian cell growth. , 2010, Nano letters.

[13]  W. D. de Jong,et al.  Nano-silver – a review of available data and knowledge gaps in human and environmental risk assessment , 2009 .

[14]  Yongsheng Chen,et al.  Modeling the primary size effects of citrate-coated silver nanoparticles on their ion release kinetics. , 2011, Environmental science & technology.

[15]  Tahlia L. Weis,et al.  Surfaces modified with nanometer-thick silver-impregnated polymeric films that kill bacteria but support growth of mammalian cells. , 2010, Biomaterials.

[16]  A. Khan,et al.  Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections , 2011 .

[17]  H J Klasen,et al.  Historical review of the use of silver in the treatment of burns. I. Early uses. , 2000, Burns : journal of the International Society for Burn Injuries.

[18]  M Epple,et al.  Uptake and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. , 2011, Acta biomaterialia.

[19]  Michael Wagener,et al.  An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. , 2004, Biomaterials.

[20]  Shiyuan Ding,et al.  Preparation of silver nanoparticles by chemical reduction method , 2005 .

[21]  C. Che,et al.  Oxidative dissolution of silver nanoparticles by biologically relevant oxidants: a kinetic and mechanistic study. , 2010, Chemistry, an Asian journal.

[22]  M. Epple,et al.  Synthesis of PVP‐coated silver nanoparticles and their biological activity towards human mesenchymal stem cells , 2009 .

[23]  Matthias Epple,et al.  TOXICITY OF SILVER NANOPARTICLES INCREASES DURING STORAGE BECAUSE OF SLOW DISSOLUTION UNDER RELEASE OF SILVER IONS , 2010 .

[24]  M. Epple,et al.  Accumulation of silver nanoparticles by cultured primary brain astrocytes , 2011, Nanotechnology.

[25]  B. Gibbins,et al.  Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. , 2008, The Journal of antimicrobial chemotherapy.

[26]  C. Murphy,et al.  Polymeric Multilayers that Contain Silver Nanoparticles can be Stamped onto Biological Tissues to Provide Antibacterial Activity , 2011, Advanced functional materials.

[27]  B. Levin,et al.  Functional relationship between bacterial cell density and the efficacy of antibiotics. , 2009, The Journal of antimicrobial chemotherapy.

[28]  C. Milanese,et al.  Synthesis, characterization and antibacterial activity against Gram positive and Gram negative bacteria of biomimetically coated silver nanoparticles. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[29]  L. Macera,et al.  Evidence‐based review of silver dressing use on chronic wounds , 2011, Journal of the American Academy of Nurse Practitioners.

[30]  M. Epple,et al.  Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs) , 2009, Langenbeck's Archives of Surgery.

[31]  M. Yacamán,et al.  The bactericidal effect of silver nanoparticles , 2005, Nanotechnology.

[32]  Bernd Nowack,et al.  120 years of nanosilver history: implications for policy makers. , 2011, Environmental science & technology.

[33]  R. Hurt,et al.  Controlled release of biologically active silver from nanosilver surfaces. , 2010, ACS nano.

[34]  R. Hurt,et al.  Ion release kinetics and particle persistence in aqueous nano-silver colloids. , 2010, Environmental science & technology.

[35]  Facundo Ruiz,et al.  Synthesis and antibacterial activity of silver nanoparticles with different sizes , 2008 .

[36]  Tetsuaki Tsuchido,et al.  Mode of Bactericidal Action of Silver Zeolite and Its Comparison with That of Silver Nitrate , 2003, Applied and Environmental Microbiology.

[37]  Helinor J Johnston,et al.  A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity , 2010, Critical reviews in toxicology.

[38]  B. Andersen,et al.  Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. , 1974, Journal of immunological methods.

[39]  J. Trevors,et al.  Bacterial interactions with silver , 2005, Biology of Metals.

[40]  J. Maessen,et al.  The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. , 2009, Biomaterials.

[41]  Siddhartha P Duttagupta,et al.  Strain specificity in antimicrobial activity of silver and copper nanoparticles. , 2008, Acta biomaterialia.

[42]  K. Siebenrock,et al.  In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations , 2013, Nanotoxicology.

[43]  J. Schlager,et al.  DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. , 2008, Toxicology and applied pharmacology.

[44]  X. Chen,et al.  Nanosilver: a nanoproduct in medical application. , 2008, Toxicology letters.